GGrantIndex
Sort

261,768 grants matching gene therapy

Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)

$857,217
Michael John McGeachie · Brigham And Women'S Hospital · R01 · FY2021 · HL

Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations

$857,021
Lisa Forbes · Baylor College Of Medicine · UH3 · FY2025 · TR

Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level

$856,949
Ya-Chi Ho · Yale University · R01 · FY2023 · AI

Development of novel genomic approaches for profiling cellular temporal-spatial dynamics of neurogenesis in Aging and Alzheimer's disease

$856,906
Junyue Cao · Rockefeller University · R01 · FY2022 · AG

Regulation of Aldosterone: The Effect of Statins

$856,893
Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2020 · HL

Gene Therapy Resource Program Clinical Coordinating Center

$856,885
Susan Sepelak · Social And Scientific Systems, Inc. · N01 · FY2015 · HL

Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients

$856,882
Joren C Madsen · Massachusetts General Hospital · U01 · FY2012 · AI

Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients

$856,882
Joren C Madsen · Massachusetts General Hospital · U01 · FY2014 · AI

Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis

$856,782
Chad Allen Koplinski · Xlock Biosciences, Llc · R44 · FY2020 · AR

Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme

$856,769
Diako Ebrahimi · Texas Biomedical Research Institute · R01 · FY2024 · AI

Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities

$856,702
Charles T Roberts · Oregon Health & Science University · R01 · FY2019 · DK

Systematic Characterization and Targeting of Neomorphic Drivers in Cancer

$856,656
Gordon B. Mills · Oregon Health & Science University · U01 · FY2025 · CA

AC5 inhibitor for heart failure

$856,579
Dorothy E Vatner · Vasade Biosciences, Inc. · R44 · FY2014 · HL

Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma

$856,578
Peter Qinhua Huang · Zeno Management, Inc · R44 · FY2019 · CA

Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy

$856,540
Reuben Kapur · Indiana University Indianapolis · U54 · FY2025 · DK

Robust verification of genetic variant-associated candidate off-target sites

$856,513
Daniel Evan Bauer · Boston Children'S Hospital · U01 · FY2025 · AI

Ultrasensitive C.difficile toxin measurement for diagnosis and outcome prediction

$856,476
Nira Pollock · Beth Israel Deaconess Medical Center · R01 · FY2016 · AI

Hormone Receptors and Genes Regulating Gonadal and mammary function

$856,470
Maria Dufau · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

Cancer Etiology, Prevention, Detection and Diagnosis

$856,459
Amato J. Giaccia · Stanford University · T32 · FY2011 · CA

Impact of Stretching on Tumor growth and Metastasis

$856,418
Helene Langevin · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE

Preventing GVHD by inhibition of alloantigen presentation in the gut

$856,395
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2023 · HL

Novel Targets for Vaccine Therapy

$856,385
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells

$856,355
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Angiogenesis and Tumor Growth

$856,318
Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA

Study of the Roles of SDF1 and CXCR4 in Hematopoiesis

$856,318
Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA